Goldman Sachs
XFOR icon

Goldman Sachs’s X4 Pharmaceuticals XFOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$35.8K Sell
18,864
-255,001
-93% -$485K ﹤0.01% 5008
2025
Q1
$64.7K Sell
273,865
-203,773
-43% -$48.2K ﹤0.01% 4884
2024
Q4
$350K Buy
477,638
+185,053
+63% +$136K ﹤0.01% 4465
2024
Q3
$196K Buy
292,585
+121,395
+71% +$81.3K ﹤0.01% 4500
2024
Q2
$99.3K Sell
171,190
-887,740
-84% -$515K ﹤0.01% 4501
2024
Q1
$1.47M Buy
1,058,930
+986,142
+1,355% +$1.37M ﹤0.01% 3370
2023
Q4
$61K Buy
72,788
+23,195
+47% +$19.4K ﹤0.01% 4524
2023
Q3
$54.1K Sell
49,593
-284,848
-85% -$310K ﹤0.01% 4477
2023
Q2
$649K Buy
334,441
+250,959
+301% +$487K ﹤0.01% 3843
2023
Q1
$72.6K Buy
83,482
+28,502
+52% +$24.8K ﹤0.01% 4712
2022
Q4
$54.6K Sell
54,980
-400
-0.7% -$397 ﹤0.01% 4777
2022
Q3
$95K Buy
+55,380
New +$95K ﹤0.01% 4932
2022
Q1
Sell
-20,949
Closed -$48K 5906
2021
Q4
$48K Buy
20,949
+10,474
+100% +$24K ﹤0.01% 5363
2021
Q3
$55K Sell
10,475
-43,532
-81% -$229K ﹤0.01% 5171
2021
Q2
$351K Sell
54,007
-29,030
-35% -$189K ﹤0.01% 4622
2021
Q1
$715K Buy
83,037
+27,031
+48% +$233K ﹤0.01% 4135
2020
Q4
$360K Buy
56,006
+4,588
+9% +$29.5K ﹤0.01% 3998
2020
Q3
$348K Buy
51,418
+19,835
+63% +$134K ﹤0.01% 3828
2020
Q2
$294K Buy
31,583
+17,433
+123% +$162K ﹤0.01% 3836
2020
Q1
$142K Sell
14,150
-4,975
-26% -$49.9K ﹤0.01% 4070
2019
Q4
$205K Buy
19,125
+4,280
+29% +$45.9K ﹤0.01% 3979
2019
Q3
$189K Sell
14,845
-17,180
-54% -$219K ﹤0.01% 3930
2019
Q2
$480K Buy
+32,025
New +$480K ﹤0.01% 3546
2019
Q1
Sell
-23,336
Closed -$54K 4267
2018
Q4
$54K Buy
+23,336
New +$54K ﹤0.01% 3965